Skip to main content
. Author manuscript; available in PMC: 2008 Oct 7.
Published in final edited form as: Mol Cancer Ther. 2007 Aug;6(8):2188–2197. doi: 10.1158/1535-7163.MCT-07-0235

Figure 6. Rapamycin inhibits proliferation in lung metastases.

Figure 6

A/B. Representative sections (400X, bar 50μM) are shown for nuclear staining for Ki-67 in lung metastases collected from mice treated with either vehicle (A) or rapamycin (B) for 32 days. C) The graph shows the average percentage of Ki-67 positive metatstatic epithelial cells per mouse in lung metastases collected from vehicle (n=3) and rapamycin (n=4) treated mice. Error bars represent standard deviations, * = p<0.05.